
RELIVE
The RELIVE project, which consists in setting up the 1Er international registry on children relapsing from liver cancer, has established partnerships with all researchers in the CHIC consortium from all over Europe (SIOPEL), Japan (JPLT), Australia and New Zealand, as well as from Australia and New Zealand, as well as from the United States and New Zealand, as well as from the United States and Canada. The various research groups are in the process of being opened for this project and are collecting all the data related to the treatments recently used for children relapsing from liver cancer. The objective is to insert this data into an international central register, based at the Geneva University Hospitals, in order to then study how to improve the survival of these children in the future. Link to the RELIVE website: https://relive-international.net
